CBALX
Price
$56.65
Change
+$0.16 (+0.28%)
Updated
Oct 17 closing price
Net Assets
10.25B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

CBALX vs RLBCX

Header iconCBALX vs RLBCX Comparison
Open Charts CBALX vs RLBCXBanner chart's image
Columbia Balanced Inst
Price$56.65
Change+$0.16 (+0.28%)
VolumeN/A
Net Assets10.25B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
CBALX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
CBALX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBALX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. CBALX (10.2B). CBALX pays higher dividends than RLBCX: CBALX (1.79) vs RLBCX (1.49). CBALX was incepted earlier than RLBCX: CBALX (34 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than CBALX (0.68). CBALX is a more actively managed with annual turnover of: 200.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than CBALX: RLBCX (250) vs CBALX (2000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. CBALX (6.09). RLBCX return over 5 years is better than : 40.24 vs. CBALX (29.05).
CBALXRLBCXCBALX / RLBCX
Total Expense Ratio0.680.8976%
Annual Report Gross Expense Ratio0.680.8976%
Fund Existence34 years23 years-
Gain YTD12.12414.36484%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets10.2B265B4%
Annual Yield % from dividends1.791.49120%
Returns for 1 year6.098.3473%
Returns for 3 years46.0449.2693%
Returns for 5 years29.0540.2472%
Returns for 10 years74.5772.18103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals